Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
VRTXVertex Pharmaceuticals
FinDog View：Neutral
| Metric | LLY | VRTX |
|---|
| Close | 1,137.82 | 513.26 |
| Market Cap | $1.07T | $121B |
| 1M | −3.83% | −0.44% |
| P/E (TTM) | 39.9 | 29.7 |
| Forward P/E | 28.5 | 24.0 |
| P/E 5-Yr Percentile | 6 | 52 |
| P/S | 13.4 | 10.4 |
| P/B | 31.5 | 6.5 |
| Dividend Yield | 0.75% | — |
| Latest Quarter Revenue | $23.0B | $3.3B |
| Revenue YoY | +47.7% | +12.5% |
| Gross Margin | 85.8% | 85.3% |
| Latest Quarter EPS | 7.94 | 4.31 |
| Avg Post-Earnings Move | ±3.5% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.12% | 1.66% |
| 90-Day Net Insider Buying | −$16.0M | −$2.8M |
LLY · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
